Overview

Impact of Cholinesterase Inhibitors on Driving Ability in Healthy Older Adults

Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The goal of the study is to assess the role of cholinesterase inhibitors in affecting the driving ability of cognitively intact seniors using driving simulators. We hypothesize that the use of a cholinesterase inhibitor for two weeks will be associated with improvement in safe driving behavior on a simulated driving task.
Phase:
Phase 4
Details
Lead Sponsor:
Sunnybrook Health Sciences Centre
Collaborator:
University of Toronto
Treatments:
Cholinesterase Inhibitors
Donepezil